Tue, Dec 23, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Alternative Market Briefing

BofA Merrill Lynch’s investable hedge fund index up 0.93% month to date, 4.54% year to date

Wednesday, May 15, 2013

Beverly Chandler, Opalesque London: The latest Hedge Fund Monitor from Bank of America Merrill Lynch finds that macros are currently net long EAFE while short US equities. Stephen Suttmeier, Chief Equity Technical Strategist reported that the investable hedge fund composite index was up 0.93% month-to-date as of May 8, compared with a price return of 2.20% for the S&P 500 index, and had a year to date figure of 4.54%.

Key takeaways from the report include:

  • Hedge funds had a good start in May, rising 0.93% in the first week, but still underperformed S&P 500’s 2.20% advance.
  • Macro hedge funds aggressively bought EAFE exposures to near the 2012 high, while staying net short of the S&P 500 and NASDAQ 100.
  • Large speculators aggressively sold 30-year and 10-year Treasuries out of a crowded long. With Yen breaking above 100 for the first time in four years, large speculators have sizable net short positions in Yen.
In terms of performance, Convertible Arbitrage and Event Driven performed the best, up 1.29% and 1.19%, respectively. Market Neutral performed the worst and was down 0.42%.

In terms of hedge fund positioning by major strategies, BofA Merrill Lynch’s models indicate that Market Neutral funds increased market exposure to 11% from 10% net long. E......................

To view our full article Click here

Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Hong Kong-Shanghai stock link fails to live up to expectation so far[more]

    Komfie Manalo, Opalesque Asia: In a report, Reuters said that demand has been subdued with the bulk of activities coming from short-term speculative investors. Las

  2. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  3. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  4. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for

  5. CFTC Revokes Registrations of Illinois Resident Aleks A. Kins and Chicago-based AlphaMetrix, LLC[more]

    Matthias Knab, Opalesque: The U.S. Commodity Futures Trading Commission (CFTC) today announced that it has revoked the registration of Aleks A. Kins of Chicago, Illinois, as an Associated Person and the registrations of AlphaMetrix, LLC (AlphaMetrix), a Delaware limited liability company with its